Literature DB >> 31380705

Viral infections and immune reconstitution interaction after pediatric allogenic hematopoietic stem cell transplantation.

Adam Alexandersson1,2,3, Minna Koskenvuo1,2, Anette Tiderman2, Mitja Lääperi3, Pasi Huttunen1,2, Ulla Saarinen-Pihkala1, Veli-Jukka Anttila2,4, Irmeli Lautenschlager2,5, Mervi Taskinen1,2.   

Abstract

Background: Viral infections are a major cause of morbidity and mortality after hematopoietic stem cell transplantation (HSCT). Although immune suppression plays a central role, the literature shows conflicting results on interplay between post-transplant immune reconstitution (IR) and viral infections.
Methods: We prospectively studied viral infections and IR in 30 pediatric patients undergoing allogenic HSCT, with a follow-up time of 24 months. In total, 1337 blood (CMV, EBV, HHV-6, ADV and BKV) and urine (BKV and JCV) virus samples were analyzed. IR including B-cells (CD19+), T cells (CD3+, CD4+, CD8+) and NK-cells were measured. Clinical outcomes included overall survival (OS), non-relapse mortality (NRM), graft-versus-host disease (GVHD) and occurrence of blood culture positive bacterial infections.
Results: We found BKV reactivation to be most frequent, 47% of the children had viremia and 77% viruria. The frequencies of CMV, HHV-6 and adeno viremia were 37%, 37% and 6%, respectively. Viremias beyond 3 months post-HSCT were uncommon. Factors such as GVHD, use of steroids, EBV and CMV infections and pre-transplant irradiation affected IR. No specific viral infection or IR related factor was associated to OS or NRM. Conclusions: Viral infections and IR interact in a bi-directional manner. Accordingly, close follow-up of both IR and viral loads is warranted.

Entities:  

Keywords:  HSCT; Virus; immune reconstitution; pediatric; transplantation

Mesh:

Year:  2019        PMID: 31380705     DOI: 10.1080/23744235.2019.1650198

Source DB:  PubMed          Journal:  Infect Dis (Lond)        ISSN: 2374-4243


  7 in total

1.  Target Enrichment Metagenomics Reveals Human Pegivirus-1 in Pediatric Hematopoietic Stem Cell Transplantation Recipients.

Authors:  Natali Ludowyke; Worakorn Phumiphanjarphak; Nopporn Apiwattanakul; Suwimon Manopwisedjaroen; Samart Pakakasama; Insee Sensorn; Ekawat Pasomsub; Wasun Chantratita; Suradej Hongeng; Pakorn Aiewsakun; Arunee Thitithanyanont
Journal:  Viruses       Date:  2022-04-12       Impact factor: 5.818

2.  Enhancement of Antiviral T-Cell Responses by Vitamin C Suggests New Strategies to Improve Manufacturing of Virus-Specific T Cells for Adoptive Immunotherapy.

Authors:  Miriam Laubert; Agnes Bonifacius; Anna Christina Dragon; Caroline Mangare; Rainer Blasczyk; Jochen Huehn; Britta Eiz-Vesper
Journal:  Biology (Basel)       Date:  2022-03-30

3.  Infectious Complications in Paediatric Haematopoetic Cell Transplantation for Acute Lymphoblastic Leukemia: Current Status.

Authors:  Olga Zajac-Spychala; Stefanie Kampmeier; Thomas Lehrnbecher; Andreas H Groll
Journal:  Front Pediatr       Date:  2022-02-10       Impact factor: 3.418

4.  Multivariate Analysis of Immune Reconstitution and Relapse Risk Scoring in Children Receiving Allogeneic Stem Cell Transplantation for Acute Leukemias.

Authors:  Manuela Spadea; Francesco Saglio; Serena I Tripodi; Mariacristina Menconi; Marco Zecca; Franca Fagioli
Journal:  Transplant Direct       Date:  2021-10-06

5.  Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial.

Authors:  Xin Xu; Zhiping Fan; Yu Wang; Fen Huang; Yajing Xu; Jing Sun; Na Xu; Lan Deng; Xudong Li; Xinquan Liang; Xiaodan Luo; Pengcheng Shi; Hui Liu; Yan Chen; Sanfang Tu; Xiaojun Huang; Qifa Liu; Li Xuan
Journal:  BMC Med       Date:  2022-09-02       Impact factor: 11.150

6.  Comparison of ATG-thymoglobulin with ATG-Fresenius for Epstein-Barr virus infections and graft-versus-host-disease in patients with hematological malignances after haploidentical hematopoietic stem cell transplantation: a single-center experience.

Authors:  Ling Zhou; Zhi-Yong Gao; Dao-Pei Lu
Journal:  Ann Hematol       Date:  2020-04-14       Impact factor: 3.673

Review 7.  Harnessing T Cells to Control Infections After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Sabrina Basso; Francesca Compagno; Paola Zelini; Giovanna Giorgiani; Stella Boghen; Elena Bergami; Jessica Bagnarino; Mariangela Siciliano; Claudia Del Fante; Mario Luppi; Marco Zecca; Patrizia Comoli
Journal:  Front Immunol       Date:  2020-10-15       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.